Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 11 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005840 | ribosome | 5 | 13 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0043226 | organelle | 2 | 13 |
GO:0043228 | non-membrane-bounded organelle | 3 | 13 |
GO:0043229 | intracellular organelle | 3 | 13 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 13 |
GO:0110165 | cellular anatomical entity | 1 | 13 |
GO:1990904 | ribonucleoprotein complex | 2 | 12 |
Related structures:
AlphaFold database: Q4Q5X4
Term | Name | Level | Count |
---|---|---|---|
GO:0006412 | translation | 4 | 13 |
GO:0006518 | peptide metabolic process | 4 | 13 |
GO:0006807 | nitrogen compound metabolic process | 2 | 13 |
GO:0008152 | metabolic process | 1 | 13 |
GO:0009058 | biosynthetic process | 2 | 13 |
GO:0009059 | macromolecule biosynthetic process | 4 | 13 |
GO:0009987 | cellular process | 1 | 13 |
GO:0019538 | protein metabolic process | 3 | 13 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 13 |
GO:0034645 | obsolete cellular macromolecule biosynthetic process | 4 | 13 |
GO:0043043 | peptide biosynthetic process | 5 | 13 |
GO:0043170 | macromolecule metabolic process | 3 | 13 |
GO:0043603 | amide metabolic process | 3 | 13 |
GO:0043604 | amide biosynthetic process | 4 | 13 |
GO:0044237 | cellular metabolic process | 2 | 13 |
GO:0044238 | primary metabolic process | 2 | 13 |
GO:0044249 | cellular biosynthetic process | 3 | 13 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 13 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 13 |
GO:0071704 | organic substance metabolic process | 2 | 13 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 13 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 13 |
GO:1901576 | organic substance biosynthetic process | 3 | 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0003735 | structural constituent of ribosome | 2 | 13 |
GO:0005198 | structural molecule activity | 1 | 13 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 13 | 15 | PF00675 | 0.479 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.516 |
CLV_PCSK_SKI1_1 | 14 | 18 | PF00082 | 0.627 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.469 |
CLV_PCSK_SKI1_1 | 159 | 163 | PF00082 | 0.195 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.715 |
CLV_PCSK_SKI1_1 | 73 | 77 | PF00082 | 0.555 |
CLV_Separin_Metazoa | 77 | 81 | PF03568 | 0.640 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.550 |
DEG_SIAH_1 | 115 | 123 | PF03145 | 0.530 |
DEG_SPOP_SBC_1 | 111 | 115 | PF00917 | 0.746 |
DOC_MAPK_gen_1 | 162 | 172 | PF00069 | 0.284 |
DOC_MAPK_gen_1 | 197 | 205 | PF00069 | 0.417 |
DOC_MAPK_gen_1 | 35 | 45 | PF00069 | 0.656 |
DOC_MAPK_MEF2A_6 | 142 | 151 | PF00069 | 0.342 |
DOC_PP2B_LxvP_1 | 43 | 46 | PF13499 | 0.517 |
DOC_USP7_MATH_1 | 128 | 132 | PF00917 | 0.635 |
DOC_USP7_UBL2_3 | 138 | 142 | PF12436 | 0.516 |
DOC_WW_Pin1_4 | 112 | 117 | PF00397 | 0.655 |
DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.666 |
LIG_14-3-3_CanoR_1 | 13 | 21 | PF00244 | 0.600 |
LIG_14-3-3_CanoR_1 | 2 | 6 | PF00244 | 0.588 |
LIG_Actin_WH2_2 | 183 | 201 | PF00022 | 0.369 |
LIG_BRCT_BRCA1_1 | 102 | 106 | PF00533 | 0.421 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.602 |
LIG_FHA_1 | 74 | 80 | PF00498 | 0.497 |
LIG_FHA_2 | 141 | 147 | PF00498 | 0.601 |
LIG_FHA_2 | 175 | 181 | PF00498 | 0.397 |
LIG_LIR_Gen_1 | 57 | 67 | PF02991 | 0.456 |
LIG_SH2_GRB2like | 59 | 62 | PF00017 | 0.437 |
LIG_SH2_SRC | 95 | 98 | PF00017 | 0.531 |
LIG_SH2_STAP1 | 95 | 99 | PF00017 | 0.490 |
LIG_SH2_STAT5 | 59 | 62 | PF00017 | 0.455 |
LIG_SH3_3 | 113 | 119 | PF00018 | 0.666 |
LIG_TRAF2_1 | 171 | 174 | PF00917 | 0.311 |
MOD_CK2_1 | 168 | 174 | PF00069 | 0.365 |
MOD_CK2_1 | 190 | 196 | PF00069 | 0.304 |
MOD_GlcNHglycan | 102 | 105 | PF01048 | 0.584 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.617 |
MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.591 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.666 |
MOD_LATS_1 | 71 | 77 | PF00433 | 0.379 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.686 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.593 |
MOD_NEK2_1 | 145 | 150 | PF00069 | 0.335 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.620 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.644 |
MOD_PKA_2 | 100 | 106 | PF00069 | 0.655 |
MOD_PKB_1 | 12 | 20 | PF00069 | 0.503 |
MOD_Plk_1 | 140 | 146 | PF00069 | 0.499 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.645 |
MOD_ProDKin_1 | 112 | 118 | PF00069 | 0.655 |
MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.664 |
MOD_SUMO_rev_2 | 171 | 178 | PF00179 | 0.349 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.440 |
TRG_ER_diArg_1 | 11 | 14 | PF00400 | 0.605 |
TRG_NES_CRM1_1 | 163 | 174 | PF08389 | 0.230 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2G0 | Leptomonas seymouri | 58% | 100% |
A0A0S4IRA5 | Bodo saltans | 41% | 92% |
A0A0S4JKH3 | Bodo saltans | 38% | 88% |
A0A1X0NIA7 | Trypanosomatidae | 45% | 100% |
A0A3Q8IFU2 | Leishmania donovani | 90% | 100% |
A0A422NF54 | Trypanosoma rangeli | 43% | 100% |
A4HJS3 | Leishmania braziliensis | 70% | 100% |
A4I789 | Leishmania infantum | 89% | 100% |
C9ZMG8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
E9B284 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
V5BGN2 | Trypanosoma cruzi | 43% | 72% |